ALT 0.00% 0.5¢ analytica limited

The biggest issue here is the one they are not reporting on....

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,818 Posts.
    The biggest issue here is the one they are not reporting on. Where is the FDA submission up to allowing US citizens to purchase the Pericoach without a prescription? I was really annoyed at the company and myself (for not understanding this) because I don't remember reading anywhere that the approval they were after was so restrictive. If they want to increase sales they need FDA approval without a prescription so where is this at?

    Spending all this money on marketing in the US is wasteful until this occurs because most people either couldn't be bothered going to the doctor to get a script or embarrassed to go. They also have to pay to visit the doctor so it isn't just the purchase price of the pericoach they are up for.

    In my opinion they need to be smarter with their money. They should have engaged a distribution partner on commission ONLY until Pericoach could be purchased online in the US and then spent the marketing money on advertising to the broader market. This means a fixed cost per unit to sell them to start with, Going to the professionals only captures the market for people that are proactive on their health and not the public who buy items compulsory. Much smaller audience.

    Seems like a no brainer to me.
 
watchlist Created with Sketch. Add ALT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.